Research in recent years (NIOSH, IARC, NFPA, ATSDR) has linked chronic exposure to these compounds with: Increased risk of cancer Cardiovascular disease Endocrine disruption Decreased recovery capacity Thyroid dysfunction Neurological effects Impaired immune function Reduced fertility/testosterone Chronic inflammation Mitochondrial dysfunction With these effects often emerging silently over years or decades
Participants also showed improvements in glycaemic control, cardiovascular risk markers, and physical function, adding to the drugs clinical profile beyond simple weight reduction
CMS should announce the negotiated prices for the 2027 drugs by November 30, 2025, with an effective date of January 1, 2027
Side effects: Similar to injectablesnausea, diarrhea, constipation, stomach upset
Explore the benefits of B12 injections for enhancing your overall wellness and energy levels